Severino Paolo, D'Amato Andrea, Saglietto Andrea, D'Ascenzo Fabrizio, Marini Claudia, Schiavone Marco, Ghionzoli Nicolò, Pirrotta Filippo, Troiano Francesca, Cannillo Margherita, Mennuni Marco, Rognoni Andrea, Rametta Francesco, Galluzzo Alessandro, Agnes Gianluca, Infusino Fabio, Pucci Mariateresa, Lavalle Carlo, Cacciotti Luca, Mather Paul J, Grosso Marra Walter, Ugo Fabrizio, Forleo Giovanni, Viecca Maurizio, Morici Nuccia, Patti Giuseppe, De Ferrari Gaetano M, Palazzuoli Alberto, Mancone Massimo, Fedele Francesco
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico 155, Rome, 00161, Italy.
Division of Cardiology, AOU Città della Salute e della Scienza di Torino, Section of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy.
ESC Heart Fail. 2020 Dec;7(6):4182-4188. doi: 10.1002/ehf2.13043. Epub 2020 Oct 23.
The recent coronavirus disease 19 (COVID-19) pandemic outbreak forced the adoption of restraint measures, which modified the hospital admission patterns for several diseases. The aim of the study is to investigate the rate of hospital admissions for heart failure (HF) during the early days of the COVID-19 outbreak in Italy, compared with a corresponding period during the previous year and an earlier period during the same year.
We performed a retrospective analysis on HF admissions number at eight hospitals in Italy throughout the study period (21 February to 31 March 2020), compared with an inter-year period (21 February to 31 March 2019) and an intra-year period (1 January to 20 February 2020). The primary outcome was the overall rate of hospital admissions for HF. A total of 505 HF patients were included in this survey: 112 during the case period, 201 during intra-year period, and 192 during inter-year period. The mean admission rate during the case period was 2.80 admissions per day, significantly lower compared with intra-year period (3.94 admissions per day; incidence rate ratio, 0.71; 95% confidence interval [CI], 0.56-0.89; P = 0.0037), or with inter-year (4.92 admissions per day; incidence rate ratio, 0.57; 95% confidence interval, 0.45-0.72; P < 0.001). Patients admitted during study period were less frequently admitted in New York Heart Association (NYHA) Class II compared with inter-year period (P = 0.019). At covariance analysis NYHA class was significantly lower in patients admitted during inter-year control period, compared with patients admitted during case period (P = 0.014).
Admissions for HF were significantly reduced during the lockdown due to the COVID-19 pandemic in Italy.
近期新型冠状病毒肺炎(COVID-19)大流行的爆发促使采取了限制措施,这改变了多种疾病的住院模式。本研究的目的是调查意大利COVID-19疫情爆发初期心力衰竭(HF)的住院率,并与上一年同期以及同年更早时期进行比较。
我们对意大利八家医院在整个研究期间(2020年2月21日至3月31日)的HF住院人数进行了回顾性分析,并与跨年度期间(2019年2月21日至3月31日)和年度内期间(2020年1月1日至2月20日)进行比较。主要结局是HF的总体住院率。本调查共纳入505例HF患者:病例期间112例,年度内期间201例,跨年度期间192例。病例期间的平均住院率为每天2.80例,与年度内期间(每天3.94例;发病率比,0.71;95%置信区间[CI],0.56 - 0.89;P = 0.0037)或跨年度期间(每天4.92例;发病率比,0.57;95%置信区间,0.45 - 0.72;P < 0.001)相比显著降低。与跨年度期间相比,研究期间入院的患者纽约心脏协会(NYHA)II级的比例更低(P = 0.019)。在协方差分析中,跨年度对照期间入院的患者NYHA分级显著低于病例期间入院的患者(P = 0.014)。
在意大利因COVID-19大流行实施封锁期间,HF的入院人数显著减少。